PTSD Trial, Recruiting NCT06900712 Sponsor: Case Western Reserve University Condition: PTSD
Back to Ptsd

PTSD Trial, Recruiting

NCT06900712
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 65 years old
  • People who have experienced unwanted sexual contact or sexual assault, where the event happened at least 12 weeks ago but no more than 5 years ago
  • People who currently live in the state of Ohio
  • People who are experiencing at least moderate levels of post-traumatic stress or depression symptoms, as measured by specific screening questionnaires, and those symptoms have been present for at least one month

Who may not be able to join:

  • People who currently have a diagnosis of schizophrenia, delusional disorder, or an organic mental disorder
  • People who currently have a diagnosis of bipolar disorder, depression with psychotic features, or depression serious enough to require immediate psychiatric treatment, including those with a serious risk of suicide with a specific intent and plan
  • People who have seriously harmed themselves or attempted suicide in the past three months
  • People who are currently receiving cognitive behavioural therapy (a specific type of talk therapy)
  • People who do not have a clear memory of the event that occurred
  • People whose psychiatric medication doses have not been stable for the past three months
  • People who are currently in a relationship with the person who harmed them
  • People who currently have a diagnosed substance use disorder
  • People who do not live in the state of Ohio

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Norah C Feeny, PhD, Case Western Reserve University

Phone: (216) 368-2695

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Case Western Reserve University
Registry
ClinicalTrials.gov
Start date
17 July 2025
Est. completion
31 August 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

PTSD Symptom Scale-Interview (PSS-I-5; Foa et al., 2016); Quick Inventory of Depressive Symptomatology-Clinican Report (QIDS-C; Rush et al., 2003); Post-traumatic Stress Diagnostic Scale (PDS-5; Foa et al., 2016); Quick Inventory of Depressive Symptomatology Self-Report Version (QIDS-SR; Rush et al., 2003)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov